NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH OBESITY: THE POTENTIAL OF ESSENTIAL PHOSPHOLIPIDS

The role and importance of primary care physicians (general practitioners and internists) are increasingly recognized in the diagnosis and management of patients with obesity and non-alcoholic fatty liver disease (NAFLD). This article discusses a diagnostic algorithm for obesity based on the AACE/ACE-2014 classification and explores the therapeutic potential of essential phospholipids within preventive and treatment recommendations for patients with obesity-associated NAFLD. Keywords: obesity, diagnostic algorithm, non-alcoholic fatty liver disease (NAFLD), preventive and therapeutic recommendations, essential phospholipids, Hepagard Active